نتایج جستجو برای: ebola virus

تعداد نتایج: 400131  

Journal: :Bioinformatics 2015
Peter D. Karp Bonnie Berger Diane E. Kovats Thomas Lengauer Michal Linial Pardis Sabeti Winston Hide Burkhard Rost

UNLABELLED Speed is of the essence in combating Ebola; thus, computational approaches should form a significant component of Ebola research. As for the development of any modern drug, computational biology is uniquely positioned to contribute through comparative analysis of the genome sequences of Ebola strains and three-dimensional protein modeling. Other computational approaches to Ebola may ...

2017
Karin Gallandat Daniele Lantagne

The 2014 West African Ebola virus disease outbreak was the largest to date, and conflicting, chlorine-based surface disinfection protocols to interrupt disease transmission were recommended. We identified only one study documenting surface disinfection efficacy against the Ebola virus, showing a >6.6 log reduction after 5-minute exposure to 0.5% sodium hypochlorite (NaOCl) based on small-scale ...

2014
Nicholas J Beeching Manuel Fenech Catherine F Houlihan

This clinical review has been developed for The BMJ in collaboration with BMJ Best Practice, based on a regularly updated web/mobile topic that supports evidence-based decision making at the point of care. To view the complete and current version, please refer to the Ebola virus infection topic on the BMJ Best Practice website. Ebola virus disease is a severe, often fatal, zoonotic filovirus in...

Journal: :Journal of clinical microbiology 2016
Maiken Worsøe Rosenstierne Helen Karlberg Karoline Bragstad Gunnel Lindegren Malin Lundahl Stoltz Cristiano Salata Anne-Marte Bakken Kran Susanne Gjeruldsen Dudman Ali Mirazimi Anders Fomsgaard

Rapid bedside inactivation of Ebola virus would be a solution for the safety of medical and technical staff, risk containment, sample transport, and high-throughput or rapid diagnostic testing during an outbreak. We show that the commercially available Magna Pure lysis/binding buffer used for nucleic acid extraction inactivates Ebola virus. A rapid bedside inactivation method for nucleic acid t...

2015
Veljko Veljkovic Marco Goeijenbier Sanja Glisic Nevena Veljkovic Vladimir R. Perovic Milan Sencanski Donald R. Branch Slobodan Paessler Ayub Darji Mattia Mori

The large 2014/2015 Ebola virus outbreak in West Africa points out the urgent need to develop new preventive and therapeutic approaches that are effective against Ebola viruses and  can be rapidly utilized. Recently, a simple theoretical criterion for the virtual screening of molecular libraries for candidate inhibitors of Ebola virus infection was proposed. Using this method the 'drug space' w...

2017
Oleg V. Pyankov Yin Xiang Setoh Sergey A. Bodnev Judith H. Edmonds Olga G. Pyankova Stepan A. Pyankov Gabor Pali Shane Belford Louis Lu Mylinh La George Lovrecz Valentina A. Volchkova Keith J. Chappell Daniel Watterson Glenn Marsh Paul R. Young Alexander A. Agafonov Jillann F. Farmer Victor E. Volchkov Andreas Suhrbier Alexander A. Khromykh

Herein we describe production of purified equine IgG obtained from horses immunized with plasmid DNA followed by boosting with Kunjin replicon virus-like particles both encoding a modified Ebola glycoprotein. Administration of the equine IgG over 5 days to cynomolgus macaques infected 24 hours previously with a lethal dose of Ebola virus suppressed viral loads by more than 5 logs and protected ...

2015
Adam J. Kucharski Anton Camacho Francesco Checchi Ron Waldman Rebecca F. Grais Jean-Clement Cabrol Sylvie Briand Marc Baguelin Stefan Flasche Sebastian Funk W. John Edmunds

In some parts of western Africa, Ebola treatment centers (ETCs) have reached capacity. Unless capacity is rapidly scaled up, the chance to avoid a generalized Ebola epidemic will soon diminish. The World Health Organization and partners are considering additional Ebola patient care options, including community care centers (CCCs), small, lightly staffed units that could be used to isolate patie...

Journal: :The Journal of infectious diseases 1999
T P Monath

Marburg and virulent Ebola viruses are maintained in hosts that are rare and have little contact with humans or do not readily transmit virus. Bats (particularly solitary microchiropteran species) are leading contenders as reservoir hosts. Virus transfer to humans occurs by contact with the primary reservoir or via an intermediate animal that acquired infection from the reservoir and is, in tur...

2017
Shruti Baikerikar

Background Ebola viral disease is a severe and mostly fatal disease in humans caused by Ebola virus. This virus belongs to family Filoviridae and is a single-stranded negative-sense virus. There is no single treatment for this disease which puts forth the need to identify new therapy to control and treat this fatal condition. Curcumin, one of the bioactives of turmeric, has proven antiviral pro...

Journal: :Journal of virology 1999
T Maruyama L L Rodriguez P B Jahrling A Sanchez A S Khan S T Nichol C J Peters P W Parren D R Burton

The activity of antibodies against filoviruses is poorly understood but has important consequences for vaccine design and passive prophylaxis. To investigate this activity, a panel of recombinant human monoclonal antibodies to Ebola virus antigens was isolated from phage display libraries constructed from RNA from donors who recovered from infection in the 1995 Ebola virus outbreak in Kikwit, D...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید